Alexander Simon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexander Simon has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Tim Rolvien
Department of Trauma and Orthopaedic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
10 shared publications Michael Amling
Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf , Martinistrasse 52, 20246 Hamburg
8 shared publications- Felix Nikolai Schmidt
Department for Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
7 shared publications - Michael Amling
Department of Osteology and Biomechanics University Medical Center Hamburg‐Eppendorf Hamburg Germany
6 shared publications Frank Timo Beil
Department of Trauma and Orthopaedic Surgery, Division of Orthopaedics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
5 shared publications- Mikolaj Bartosik
Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 28 (1)
Depth-specific characterization of bone microarchitecture in the femoral head: implications for osteoarthritis and osteoporosis research
Background: Osteoarthritis (OA) and osteoporosis (OP) are highly prevalent musculoskeletal diseases characterized by cartilage loss and increased subchondral bone formation and by systemic bone mass reduction, respectively. The femoral head is commonly examined in both OA and OP research, yet both conditions may coexist in the same patient, making it unclear how local cartilage degeneration and systemic bone mineral density (BMD), as a marker of OP-related skeletal status, contribute to bone microarchitectural changes at different depths. Methods: Femoral heads were obtained from 30 patients undergoing primary total hip arthroplasty for hip OA. Ex vivo high-resolution peripheral quantitative computed tomography (HR-pQCT) was performed on the entire femoral head, followed by computational segmentation of the subchondral mineralized plate (SMP) and five concentric trabecular regions. Depth-specific bone microarchitectural parameters were analyzed in relation to histologically assessed cartilage degeneration and systemic BMD measured by dual-energy X-ray absorptiometry (DXA). Results: The cohort had a mean age of 75.4 ± 9.5 years, 53.3% were female, and patients spanned the spectrum of normal BMD (36.7%), osteopenia (46.7%), and osteoporosis (16.7%). Trabecular volumetric tissue mineral density (Tb.vTMD), bone volume to tissue volume (BV/TV), and trabecular thickness (Tb.Th) showed an initial decrease in the superficial trabecular regions, followed by a progressive increase toward deeper regions, whereas cyst-like void volume continuously decreased with depth and almost completely disappeared beyond 9.84 mm in depth. Cartilage degeneration independently predicted subchondral bone microstructure within the SMP and in superficial to intermediate trabecular regions (up to 13.12 mm in depth). Specifically, higher OARSI grades were associated with higher SMP.Th, Tb.vTMD, BV/TV, and Tb.Th. Systemic BMD T-score emerged as an independent predictor of trabecular bone parameters across all depths and represented the sole determinant of BV/TV and Tb.Th in the deepest trabecular region (beyond 13.12 mm depth), while cartilage degeneration was not associated with trabecular bone parameters in the deepest trabecular region. Conclusions: Our findings showcase spatially distinct contributions of cartilage degeneration and systemic skeletal status to subchondral bone remodeling, identifying depth as a critical determinant in the analysis of osteochondral alterations in hip OA. Specifically, our findings emphasize that systemic BMD should be considered a covariate in OA research and that deep regions of the femoral head should be used for OP research to minimize potential confounding by local OA-related effects.
- 3 November 2026
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 28 (1)
Open AccessDepth-specific characterization of bone microarchitecture in the femoral head: implications for osteoarthritis and osteoporosis research
Background: Osteoarthritis (OA) and osteoporosis (OP) are highly prevalent musculoskeletal diseases characterized by cartilage loss and increased subchondral bone formation and by systemic bone mass reduction, respectively. The femoral head is commonly examined in both OA and OP research, yet both conditions may coexist in the same patient, making it unclear how local cartilage degeneration and systemic bone mineral density (BMD), as a marker of OP-related skeletal status, contribute to bone microarchitectural changes at different depths. Methods: Femoral heads were obtained from 30 patients undergoing primary total hip arthroplasty for hip OA. Ex vivo high-resolution peripheral quantitative computed tomography (HR-pQCT) was performed on the entire femoral head, followed by computational segmentation of the subchondral mineralized plate (SMP) and five concentric trabecular regions. Depth-specific bone microarchitectural parameters were analyzed in relation to histologically assessed cartilage degeneration and systemic BMD measured by dual-energy X-ray absorptiometry (DXA). Results: The cohort had a mean age of 75.4 ± 9.5 years, 53.3% were female, and patients spanned the spectrum of normal BMD (36.7%), osteopenia (46.7%), and osteoporosis (16.7%). Trabecular volumetric tissue mineral density (Tb.vTMD), bone volume to tissue volume (BV/TV), and trabecular thickness (Tb.Th) showed an initial decrease in the superficial trabecular regions, followed by a progressive increase toward deeper regions, whereas cyst-like void volume continuously decreased with depth and almost completely disappeared beyond 9.84 mm in depth. Cartilage degeneration independently predicted subchondral bone microstructure within the SMP and in superficial to intermediate trabecular regions (up to 13.12 mm in depth). Specifically, higher OARSI grades were associated with higher SMP.Th, Tb.vTMD, BV/TV, and Tb.Th. Systemic BMD T-score emerged as an independent predictor of trabecular bone parameters across all depths and represented the sole determinant of BV/TV and Tb.Th in the deepest trabecular region (beyond 13.12 mm depth), while cartilage degeneration was not associated with trabecular bone parameters in the deepest trabecular region. Conclusions: Our findings showcase spatially distinct contributions of cartilage degeneration and systemic skeletal status to subchondral bone remodeling, identifying depth as a critical determinant in the analysis of osteochondral alterations in hip OA. Specifically, our findings emphasize that systemic BMD should be considered a covariate in OA research and that deep regions of the femoral head should be used for OP research to minimize potential confounding by local OA-related effects.
- Open Access
- 3 October 2026
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
Navicular fractures in elite athletes: Clarifying the evidence base of the 2025 International Foot and Ankle Sports Consensus
The recent international foot and ankle sports consensus and systematic review on navicular fractures in elite athletes addresses a highly relevant and challenging topic in sports medicine and provides valuable guidance in an area where standardized treatment and return to sport (RTS) recommendations remain limited. However, several methodological and reporting issues within the systematic review warrant clarification, given their potential influence on RTS decision‐making. The reported mean RTS time of 8.2 weeks after operative treatment of navicular stress fractures appears to result from an error in the extraction of time units. Recalculation based on the included studies, after converting all values to weeks, yields a mean RTS of approximately 19.7 weeks (4.5 months), consistent with the expert consensus recommendation of 4–6 months after surgery. Further discrepancies concern the application of the stated eligibility criteria: 5 of the 14 included studies were published outside the specified 15‐year window, and at least four involved cohorts with a mean age below 18 years despite paediatric studies being listed as an exclusion criterion. Further inconsistencies in study classification and reporting add to these concerns. We believe that clarification of these concerns is essential to ensure the reliability of the evidence base informing the consensus recommendations and to support accurate guidance for RTS decision‐making in elite athletes with navicular fractures. Level of Evidence: N/A.
- 3 October 2026
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
Open AccessNavicular fractures in elite athletes: Clarifying the evidence base of the 2025 International Foot and Ankle Sports Consensus
The recent international foot and ankle sports consensus and systematic review on navicular fractures in elite athletes addresses a highly relevant and challenging topic in sports medicine and provides valuable guidance in an area where standardized treatment and return to sport (RTS) recommendations remain limited. However, several methodological and reporting issues within the systematic review warrant clarification, given their potential influence on RTS decision‐making. The reported mean RTS time of 8.2 weeks after operative treatment of navicular stress fractures appears to result from an error in the extraction of time units. Recalculation based on the included studies, after converting all values to weeks, yields a mean RTS of approximately 19.7 weeks (4.5 months), consistent with the expert consensus recommendation of 4–6 months after surgery. Further discrepancies concern the application of the stated eligibility criteria: 5 of the 14 included studies were published outside the specified 15‐year window, and at least four involved cohorts with a mean age below 18 years despite paediatric studies being listed as an exclusion criterion. Further inconsistencies in study classification and reporting add to these concerns. We believe that clarification of these concerns is essential to ensure the reliability of the evidence base informing the consensus recommendations and to support accurate guidance for RTS decision‐making in elite athletes with navicular fractures. Level of Evidence: N/A.
- Open Access
- 24 September 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Skeletal pathologies caused by PLS3 inactivation are predominantly associated with impaired cortical bone integrity
The identification of pathogenic PLS3 variants in individuals with X-linked osteoporosis (XLO) has demonstrated the importance of the actin-bundling protein plastin-3 for skeletal integrity. We and others have previously reported that Pls3-deficient mice display a skeletal phenotype that unexpectedly affects only the cortical bone compartment. To better characterize the impact of PLS3 inactivation on bone (micro-)architectural parameters in humans, we retrospectively analyzed skeletal parameters obtained from male XLO patients and compared them to corresponding data from male individuals with genetically diagnosed osteogenesis imperfecta type I (OI-I). We observed no major differences between XLO and OI-I patients in baseline characteristics, laboratory parameters, or bone mineral density measurements by dual-energy X-ray absorptiometry (DXA). However, there was a significant difference between the two groups observed by high resolution peripheral quantitative computed tomography (HRpQCT). More specifically, XLO patients displayed significantly reduced cortical bone parameters, compared to both normal reference ranges and OI-I, especially at the distal radius. We also analyzed female heterozygous carriers of (likely) pathogenic PLS3 alleles, who were less affected compared to male XLO patients. However, two of them displayed osteoporotic fractures at a postmenopausal age, thus treatment with romosozumab, a monoclonal antibody targeting sclerostin, was initiated and appeared to be effective. Since another sclerostin-neutralizing antibody is currently studied for the treatment of OI patients, we crossed Pls3-deficient mice with mice carrying a high bone mass allele of Lrp5 (Lrp5A213V), which serves as a molecular mimic of anti-sclerostin therapy. We found that the presence of the Lrp5A213V allele led to significantly increased cortical and trabecular bone mass not only in wildtype but also in Pls3-deficient mice. Taken together, our data raise the hypothesis that PLS3 inactivation predominantly affects cortical bone parameters in mice and humans and that anti-sclerostin therapy could be effective for the treatment of XLO.
- 24 September 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Open AccessSkeletal pathologies caused by PLS3 inactivation are predominantly associated with impaired cortical bone integrity
The identification of pathogenic PLS3 variants in individuals with X-linked osteoporosis (XLO) has demonstrated the importance of the actin-bundling protein plastin-3 for skeletal integrity. We and others have previously reported that Pls3-deficient mice display a skeletal phenotype that unexpectedly affects only the cortical bone compartment. To better characterize the impact of PLS3 inactivation on bone (micro-)architectural parameters in humans, we retrospectively analyzed skeletal parameters obtained from male XLO patients and compared them to corresponding data from male individuals with genetically diagnosed osteogenesis imperfecta type I (OI-I). We observed no major differences between XLO and OI-I patients in baseline characteristics, laboratory parameters, or bone mineral density measurements by dual-energy X-ray absorptiometry (DXA). However, there was a significant difference between the two groups observed by high resolution peripheral quantitative computed tomography (HRpQCT). More specifically, XLO patients displayed significantly reduced cortical bone parameters, compared to both normal reference ranges and OI-I, especially at the distal radius. We also analyzed female heterozygous carriers of (likely) pathogenic PLS3 alleles, who were less affected compared to male XLO patients. However, two of them displayed osteoporotic fractures at a postmenopausal age, thus treatment with romosozumab, a monoclonal antibody targeting sclerostin, was initiated and appeared to be effective. Since another sclerostin-neutralizing antibody is currently studied for the treatment of OI patients, we crossed Pls3-deficient mice with mice carrying a high bone mass allele of Lrp5 (Lrp5A213V), which serves as a molecular mimic of anti-sclerostin therapy. We found that the presence of the Lrp5A213V allele led to significantly increased cortical and trabecular bone mass not only in wildtype but also in Pls3-deficient mice. Taken together, our data raise the hypothesis that PLS3 inactivation predominantly affects cortical bone parameters in mice and humans and that anti-sclerostin therapy could be effective for the treatment of XLO.
- Open Access
- 21 July 2026
- Published by Springer Nature in Calcified Tissue International
- Vol. 117 (1) , 117
Distinct Cortical Microstructure in Postmenopausal Women with Distal Radius and Proximal Humerus Fractures
Distal radius fractures and proximal humerus fractures are common fractures in postmenopausal women with osteoporosis. The question of whether bone microstructural deficits are reflected in specific changes in bone microstructure at peripheral skeletal sites has not yet been investigated. In this retrospective study, treatment-naïve postmenopausal women with distal radius fractures (DRF) or proximal humerus fractures (PHF) were included. Of more than 500 patients screened, 30 patients with DRF and 30 patients with PHF were included in the final analysis following propensity score matching. All participants underwent biochemical testing, dual-energy X-ray absorptiometry assessment, and bone microstructural evaluation by high-resolution peripheral quantitative computed tomography. After propensity score matching, both groups showed no significant differences in terms of age, weight, height, BMI, and lowest T-score (all p > 0.05). Mean age was 64.4 ± 10.7 years in the DRF group and 66.7 ± 9.0 years in the PHF group ( p = 0.365). In both groups, the lowest mean T-score was − 2.9 ( p = 0.539). Overall, both groups showed a reduction in total BMD and microarchitectural parameters compared to reference values at the distal radius and tibia. The PHF group exhibited significantly reduced bone geometry at the distal radius compared with the DRF group, including lower total area (p = 0.004), trabecular area ( p = 0.021), and cortical area ( p = 0.006), as well as reduced cortical thickness at both the distal radius ( p = 0.031) and tibia ( p = 0.024). PHF are characterized by reduced cortical thickness and unfavorable bone geometry, which is independent of areal bone mineral density.
- 21 July 2026
- Published by Springer Nature in Calcified Tissue International
- Vol. 117 (1) , 117
Open AccessDistinct Cortical Microstructure in Postmenopausal Women with Distal Radius and Proximal Humerus Fractures
Distal radius fractures and proximal humerus fractures are common fractures in postmenopausal women with osteoporosis. The question of whether bone microstructural deficits are reflected in specific changes in bone microstructure at peripheral skeletal sites has not yet been investigated. In this retrospective study, treatment-naïve postmenopausal women with distal radius fractures (DRF) or proximal humerus fractures (PHF) were included. Of more than 500 patients screened, 30 patients with DRF and 30 patients with PHF were included in the final analysis following propensity score matching. All participants underwent biochemical testing, dual-energy X-ray absorptiometry assessment, and bone microstructural evaluation by high-resolution peripheral quantitative computed tomography. After propensity score matching, both groups showed no significant differences in terms of age, weight, height, BMI, and lowest T-score (all p > 0.05). Mean age was 64.4 ± 10.7 years in the DRF group and 66.7 ± 9.0 years in the PHF group ( p = 0.365). In both groups, the lowest mean T-score was − 2.9 ( p = 0.539). Overall, both groups showed a reduction in total BMD and microarchitectural parameters compared to reference values at the distal radius and tibia. The PHF group exhibited significantly reduced bone geometry at the distal radius compared with the DRF group, including lower total area (p = 0.004), trabecular area ( p = 0.021), and cortical area ( p = 0.006), as well as reduced cortical thickness at both the distal radius ( p = 0.031) and tibia ( p = 0.024). PHF are characterized by reduced cortical thickness and unfavorable bone geometry, which is independent of areal bone mineral density.
- Open Access
- 19 June 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 219, 327-340
Multiscale imaging reveals compartment-specific mechanobiology of the osteochondral unit in knee osteoarthritis
- 19 June 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 219, 327-340
Open AccessMultiscale imaging reveals compartment-specific mechanobiology of the osteochondral unit in knee osteoarthritis
- Open Access
- 25 April 2026
- Published by Springer Nature in Osteoporosis International
- Vol. 37 (5) , 1337-1342
Successful treatment using asfotase alfa for delayed healing of a metatarsal stress fracture in an adolescent girl with hypophosphatasia
Hypophosphatasia (HPP) is a rare metabolic bone disorder that can present with a wide spectrum of skeletal and extraskeletal signs and symptoms. Biochemically, HPP is characterized by a decreased activity of the tissue nonspecific alkaline phosphatase (TNSALP) and subsequent accumulation of inorganic pyrophosphate (PPi). Fractures in patients with HPP can show delayed healing or even progress to nonunion. In pediatric patients, fractures can be particularly debilitating, as children usually engage in high levels of physical activity. The 16-year-old girl, carrying a pathogenic variant in the ALPL gene, presented 17 weeks (4 months) after the initial diagnosis of a fracture at the base of the fifth metatarsal (MT-V). The patient was still symptomatic, and magnetic resonance imaging and cone beam computed tomography (CBCT) showed no radiological signs of healing despite immobilization. Given the prolonged absence of fracture consolidation, TNSALP enzyme replacement therapy with asfotase alfa (AA) was initiated and dosed according to body weight, in line with approved pediatric regimens. Thirteen weeks after initiation of AA, CBCT demonstrated full radiological consolidation. Furthermore, bone mineral density (BMD) in the fracture gap increased by 36%, returning to the average BMD level of the MT-V. Here we present, to the best of our knowledge, the first pediatric case in which treatment with AA supported healing of a delayed union stress fracture in the context of clinically diagnosed and genetically supported HPP. Our findings support considering AA initiation in pediatric patients diagnosed with HPP who present delayed fracture healing despite standard conservative management.
- 25 April 2026
- Published by Springer Nature in Osteoporosis International
- Vol. 37 (5) , 1337-1342
Open AccessSuccessful treatment using asfotase alfa for delayed healing of a metatarsal stress fracture in an adolescent girl with hypophosphatasia
Hypophosphatasia (HPP) is a rare metabolic bone disorder that can present with a wide spectrum of skeletal and extraskeletal signs and symptoms. Biochemically, HPP is characterized by a decreased activity of the tissue nonspecific alkaline phosphatase (TNSALP) and subsequent accumulation of inorganic pyrophosphate (PPi). Fractures in patients with HPP can show delayed healing or even progress to nonunion. In pediatric patients, fractures can be particularly debilitating, as children usually engage in high levels of physical activity. The 16-year-old girl, carrying a pathogenic variant in the ALPL gene, presented 17 weeks (4 months) after the initial diagnosis of a fracture at the base of the fifth metatarsal (MT-V). The patient was still symptomatic, and magnetic resonance imaging and cone beam computed tomography (CBCT) showed no radiological signs of healing despite immobilization. Given the prolonged absence of fracture consolidation, TNSALP enzyme replacement therapy with asfotase alfa (AA) was initiated and dosed according to body weight, in line with approved pediatric regimens. Thirteen weeks after initiation of AA, CBCT demonstrated full radiological consolidation. Furthermore, bone mineral density (BMD) in the fracture gap increased by 36%, returning to the average BMD level of the MT-V. Here we present, to the best of our knowledge, the first pediatric case in which treatment with AA supported healing of a delayed union stress fracture in the context of clinically diagnosed and genetically supported HPP. Our findings support considering AA initiation in pediatric patients diagnosed with HPP who present delayed fracture healing despite standard conservative management.
- Open Access
- 14 April 2026
- Published by Elsevier in Bone Reports
- Vol. 29, 101918
Bone turnover in postmenopausal women during denosumab treatment: Biomarker analysis in naive and discontinuing patients
- 14 April 2026
- Published by Elsevier in Bone Reports
- Vol. 29, 101918
Open AccessBone turnover in postmenopausal women during denosumab treatment: Biomarker analysis in naive and discontinuing patients
- Open Access
- 1 October 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 206, 150-159
Spatio-temporal characterization of compositional and cellular properties in the murine fracture callus
- 1 October 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 206, 150-159
Open AccessSpatio-temporal characterization of compositional and cellular properties in the murine fracture callus
- Open Access
- 1 October 2025
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 16 (5)
Impact of Relative Energy Deficiency in Sport (REDs) on Bone Health in Elite Athletes: A Retrospective Analysis
Background: Relative energy deficiency in sport (REDs) is associated with impaired performance and compromised bone health in elite athletes. While reduced bone mineral density (BMD) and increased risk for bone stress injuries are well documented, the underlying metabolic mechanisms remain poorly understood. This study investigates the bone metabolism in athletes with REDs and its impact on BMD and bone microstructure. Methods: We retrospectively analysed data from 82 elite athletes (30.5% females, age 23.4 ± 7.6 years) who presented to our outpatient clinic. The diagnosis of REDs was made according to the International Olympic Committee REDs Clinical Assessment Tool Version 2 (IOC REDs CAT2), and athletes were categorised into strength‐based vs. endurance‐based sports. Laboratory assessment of calcium and bone metabolism included bone turnover markers such as osteocalcin, procollagen type 1 N‐terminal propeptide (P1NP) and urinary deoxypyridinoline (DPD). Areal BMD with corresponding Z ‐score was measured by dual‐energy X‐ray absorptiometry (DXA) at the lumbar spine and hip. Volumetric BMD and bone microstructure were assessed by high‐resolution peripheral quantitative computed tomography (HR‐pQCT) at the distal radius and tibia. Results: REDs was diagnosed in 24% of the athletes, and stress fractures were observed more frequently in athletes with REDs compared with those without REDs (70% vs. 25%, p < 0.001). Athletes with REDs showed significantly lower haemoglobin and haematocrit levels ( p < 0.05). Osteocalcin and P1NP were reduced in REDs compared with athletes of strength‐based disciplines ( p < 0.01), while urinary DPD/creatinine and calcium excretion were elevated ( p < 0.05), indicating suppressed bone formation and increased bone resorption, respectively. Athletes with REDs exhibited significantly reduced Z ‐scores at the lumbar spine and hip compared with strength and endurance athletes without REDs ( p < 0.05). HR‐pQCT revealed significantly lower bone volume to tissue volume and trabecular BMD at the distal radius and tibia, with more pronounced effects at the load‐bearing tibia ( p < 0.01). Similarly, trabecular number and cortical thickness were reduced in REDs, while no differences were observed in trabecular thickness. Conclusion: Athletes with REDs are characterised by a catabolic bone metabolism, marked by reduced bone formation alongside increased bone resorption. The resulting metabolic imbalance compromises skeletal adaptations to mechanical loading and contributes to decreased BMD and deteriorated bone microstructure, particularly at weight‐bearing sites. These findings underscore the shared key features of REDs and cachexia and highlight the need for early identification and management of REDs to prevent bone stress injuries and preserve athletic performance. Monitoring bone metabolism may support targeted treatment and improve outcomes in affected athletes.
- 1 October 2025
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 16 (5)
Open AccessImpact of Relative Energy Deficiency in Sport (REDs) on Bone Health in Elite Athletes: A Retrospective Analysis
Background: Relative energy deficiency in sport (REDs) is associated with impaired performance and compromised bone health in elite athletes. While reduced bone mineral density (BMD) and increased risk for bone stress injuries are well documented, the underlying metabolic mechanisms remain poorly understood. This study investigates the bone metabolism in athletes with REDs and its impact on BMD and bone microstructure. Methods: We retrospectively analysed data from 82 elite athletes (30.5% females, age 23.4 ± 7.6 years) who presented to our outpatient clinic. The diagnosis of REDs was made according to the International Olympic Committee REDs Clinical Assessment Tool Version 2 (IOC REDs CAT2), and athletes were categorised into strength‐based vs. endurance‐based sports. Laboratory assessment of calcium and bone metabolism included bone turnover markers such as osteocalcin, procollagen type 1 N‐terminal propeptide (P1NP) and urinary deoxypyridinoline (DPD). Areal BMD with corresponding Z ‐score was measured by dual‐energy X‐ray absorptiometry (DXA) at the lumbar spine and hip. Volumetric BMD and bone microstructure were assessed by high‐resolution peripheral quantitative computed tomography (HR‐pQCT) at the distal radius and tibia. Results: REDs was diagnosed in 24% of the athletes, and stress fractures were observed more frequently in athletes with REDs compared with those without REDs (70% vs. 25%, p < 0.001). Athletes with REDs showed significantly lower haemoglobin and haematocrit levels ( p < 0.05). Osteocalcin and P1NP were reduced in REDs compared with athletes of strength‐based disciplines ( p < 0.01), while urinary DPD/creatinine and calcium excretion were elevated ( p < 0.05), indicating suppressed bone formation and increased bone resorption, respectively. Athletes with REDs exhibited significantly reduced Z ‐scores at the lumbar spine and hip compared with strength and endurance athletes without REDs ( p < 0.05). HR‐pQCT revealed significantly lower bone volume to tissue volume and trabecular BMD at the distal radius and tibia, with more pronounced effects at the load‐bearing tibia ( p < 0.01). Similarly, trabecular number and cortical thickness were reduced in REDs, while no differences were observed in trabecular thickness. Conclusion: Athletes with REDs are characterised by a catabolic bone metabolism, marked by reduced bone formation alongside increased bone resorption. The resulting metabolic imbalance compromises skeletal adaptations to mechanical loading and contributes to decreased BMD and deteriorated bone microstructure, particularly at weight‐bearing sites. These findings underscore the shared key features of REDs and cachexia and highlight the need for early identification and management of REDs to prevent bone stress injuries and preserve athletic performance. Monitoring bone metabolism may support targeted treatment and improve outcomes in affected athletes.
- Open Access
- 11 May 2025
- Published by Wiley in Scandinavian Journal of Medicine & Science in Sports
- Vol. 35 (5) , e70063
Biomechanical Changes During Running on a Lower Body Positive Pressure Treadmill in Competitive Runners
Lower body positive pressure treadmills (LBPPTs) offer precise body weight unloading for injury rehabilitation and performance training in runners. This study investigated biomechanical changes during running at varying body weight support (BWS) levels (0%–80%) in competitive runners, including sex‐specific responses. Twenty‐six runners (age: 33.6 ± 9.8 years; 15 female, 11 male) completed randomized 3‐min running bouts at 12 km/h across nine BWS levels. Spatiotemporal parameters, plantar force, peak tibial acceleration, and running stability were measured using pressure insoles and inertial sensors placed at the tibia and foot. Our results revealed significant reductions in step rate (b = −0.24 steps•min−1/%BWS, p < 0.001), normalized ground contact time (b = −0.001 1/%BWS, p < 0.001), maximum plantar force (b = −0.010 BW/%BWS, p < 0.001), and peak tibial acceleration (b = −0.03 g/%BWS, p < 0.001) with increased BWS. Swing time increased (b = 1.50 ms/%BWS, p < 0.001), while stance time decreased (b = −0.41 ms/%BWS, p < 0.001). Running stability showed marginal changes (foot: b = −0.001 1/%BWS, p = 0.017; tibia: b = 0.001 1/%BWS, p = 0.009). Sex differences were observed in step rate (b = −6.79 steps•min−1, p = 0.045) and maximum plantar force (b = −0.128 BW, p = 0.034), but there were no significant sex × BWS interaction effects for any of the investigated parameters. Findings from this study highlight the effectiveness of LBPPTs for reducing musculoskeletal loading while revealing associated gait changes. Athletes, therapists, and coaches should consider individual biomechanical responses to optimize rehabilitation and performance strategies. Future research should explore long‐term adaptations and injury prevention outcomes.
- 11 May 2025
- Published by Wiley in Scandinavian Journal of Medicine & Science in Sports
- Vol. 35 (5) , e70063
Open AccessBiomechanical Changes During Running on a Lower Body Positive Pressure Treadmill in Competitive Runners
Lower body positive pressure treadmills (LBPPTs) offer precise body weight unloading for injury rehabilitation and performance training in runners. This study investigated biomechanical changes during running at varying body weight support (BWS) levels (0%–80%) in competitive runners, including sex‐specific responses. Twenty‐six runners (age: 33.6 ± 9.8 years; 15 female, 11 male) completed randomized 3‐min running bouts at 12 km/h across nine BWS levels. Spatiotemporal parameters, plantar force, peak tibial acceleration, and running stability were measured using pressure insoles and inertial sensors placed at the tibia and foot. Our results revealed significant reductions in step rate (b = −0.24 steps•min−1/%BWS, p < 0.001), normalized ground contact time (b = −0.001 1/%BWS, p < 0.001), maximum plantar force (b = −0.010 BW/%BWS, p < 0.001), and peak tibial acceleration (b = −0.03 g/%BWS, p < 0.001) with increased BWS. Swing time increased (b = 1.50 ms/%BWS, p < 0.001), while stance time decreased (b = −0.41 ms/%BWS, p < 0.001). Running stability showed marginal changes (foot: b = −0.001 1/%BWS, p = 0.017; tibia: b = 0.001 1/%BWS, p = 0.009). Sex differences were observed in step rate (b = −6.79 steps•min−1, p = 0.045) and maximum plantar force (b = −0.128 BW, p = 0.034), but there were no significant sex × BWS interaction effects for any of the investigated parameters. Findings from this study highlight the effectiveness of LBPPTs for reducing musculoskeletal loading while revealing associated gait changes. Athletes, therapists, and coaches should consider individual biomechanical responses to optimize rehabilitation and performance strategies. Future research should explore long‐term adaptations and injury prevention outcomes.